High materiality9/10
Medline price target lowered to $47 from $54 at BMO Capital
Why it may matterVerify against the original reporting
Very bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital lowers target to $47 vs price $36.67; implied upside ~28%.
- BMO Capital target $47 vs price $36.67; ~28% upside.
Key facts
- 01
Target: $71
- 02
Posted price: $66.78
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Andrew Percoco
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.